Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)
76.12
-3.69 (-4.62%)
Aug 14, 2025, 2:45 PM CST
SHA:688050 Revenue
Eyebright Medical Technology (Beijing) had revenue of 357.18M CNY in the quarter ending March 31, 2025, with 15.07% growth. This brings the company's revenue in the last twelve months to 1.46B, up 35.92% year-over-year. In the year 2024, Eyebright Medical Technology (Beijing) had annual revenue of 1.41B with 48.24% growth.
Revenue (ttm)
1.46B
Revenue Growth
+35.92%
P/S Ratio
10.60
Revenue / Employee
635.05K
Employees
2,294
Market Cap
15.44B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.41B | 458.85M | 48.24% |
Dec 31, 2023 | 951.18M | 371.68M | 64.14% |
Dec 31, 2022 | 579.50M | 146.43M | 33.81% |
Dec 31, 2021 | 433.07M | 160.02M | 58.61% |
Dec 31, 2020 | 273.05M | 77.85M | 39.88% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 41.48B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |